Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation

Area of Science:

• Molecular Biology
• Cellular Signaling
• Oncogenesis

Background:

• Signal transducers and activators of transcription factors (STATs) regulate cellular responses to external stimuli.
• Dysregulated STAT activity, particularly STAT3, is linked to human tumor development.
• Pyk2, a focal adhesion kinase, is activated by various signaling pathways but its role in STAT protein activation is not fully understood.

Purpose of the Study:

• To investigate the role of Pyk2 in epidermal growth factor receptor (EGFR)-mediated activation of Signal Transducers and Activators of Transcription 3 (STAT3).

Main Methods:

• Utilized reporter gene assays to assess STAT3 activation in HeLa cells.
• Examined STAT3 phosphorylation at Tyr-705 and Ser-727.
• Investigated the effect of dominant-negative Pyk2 and c-Src constructs on STAT3 activation and cell proliferation.
• Analyzed protein recruitment and phosphorylation upon EGF treatment in A431 cells.

Main Results:

• Pyk2 expression induced STAT3 reporter gene activation and phosphorylation.
• Co-expression of Pyk2 and c-Src potently activated STAT3 and enhanced cell proliferation.
• Dominant-negative Pyk2 impaired c-Src-induced STAT3 activation and proliferation.
• EGF treatment led to the recruitment and phosphorylation of c-Src, Pyk2, and STAT3 at the EGFR; dominant-negative Pyk2 or c-Src inhibited this process.

Conclusions:

• Pyk2 facilitates EGFR- and c-Src-mediated STAT3 activation.
• Pyk2 acts as a co-mediator in pathways triggering STAT3-induced oncogenesis.